tiprankstipranks
IPG Photonics Corporation (IPGP)
NASDAQ:IPGP

IPG Photonics (IPGP) AI Stock Analysis

721 Followers

Top Page

IPGP

IPG Photonics

(NASDAQ:IPGP)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
$120.00
▲(5.32% Upside)
Action:ReiteratedDate:03/17/26
The score is driven primarily by a strong, low-risk balance sheet but tempered by weak 2025 cash flow and only partial profitability recovery. Earnings-call signals (book-to-bill >1 and improving mix) support the outlook, while the very high P/E and recent technical softening limit upside confidence, with patent litigation adding a smaller but notable risk.
Positive Factors
Strong, debt-free balance sheet
IPG’s essentially debt‑free capital structure and large liquid position provide durable financial flexibility to fund R&D, the announced CapEx program, buybacks, and working capital through industrial cycles. This reduces solvency risk and supports strategic investments without reliance on external financing during 2–6 months and beyond.
Negative Factors
Weakened cash conversion / negative FCF
2025 saw a material drop in operating cash flow and slightly negative free cash flow despite returning to net income. Persistently weaker cash conversion reduces internal funding capacity for CapEx and growth initiatives, increases reliance on cash reserves, and raises execution risk if revenue or margin trends falter.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong, debt-free balance sheet
IPG’s essentially debt‑free capital structure and large liquid position provide durable financial flexibility to fund R&D, the announced CapEx program, buybacks, and working capital through industrial cycles. This reduces solvency risk and supports strategic investments without reliance on external financing during 2–6 months and beyond.
Read all positive factors

IPG Photonics (IPGP) vs. SPDR S&P 500 ETF (SPY)

IPG Photonics Business Overview & Revenue Model

Company Description
IPG Photonics Corporation develops, manufactures, and sells various high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide. The company's laser products include hy...
How the Company Makes Money
IPG Photonics makes money primarily by selling fiber lasers and laser-based systems used in industrial manufacturing. Its core revenue stream is product sales of fiber lasers (including high-power lasers used for metal cutting and welding and othe...

IPG Photonics Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down sales by region, showing exposure to key markets like China, North America, and Europe. Geographic mix matters for growth prospects and risks: heavy reliance on a single region can amplify impacts from local downturns, trade measures, or currency swings, while diversification points to broader market reach and resilience.
Chart InsightsIPG’s revenue mix is shifting decisively toward Asia — the region is now the primary growth engine, fueled by welding and battery demand — while North America and Europe have softened and become more lumpy. Management says the North America sequential drop reflects timing of large orders, implying short-term volatility rather than structural collapse, but elevated operating expenses and a ~140bp tariff headwind amplify execution risk if Asia slows. New medical and directed‑energy wins diversify end markets, yet near-term earnings depend on margin recovery and order timing.
Data provided by:The Fly

IPG Photonics Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The call conveyed a predominantly positive tone: management reported a strong Q4 beat, the company's first full-year revenue growth since 2021, growing contribution from higher-margin and emerging markets (medical, micromachining, advanced applications), solid cash and no debt, and product/technology milestones (awards, BUV demo, Crossbow launch). Headwinds were acknowledged—tariff-related margin pressure, under-absorption from inventory decisions, higher product costs, and some timing-related order shipping into future quarters—along with increased 2026 CapEx. Overall, the positive operational momentum, diversified growth drivers, robust balance sheet, and book-to-bill >1 outweigh the margin and timing challenges, but management remains cautiously optimistic.
Positive Updates
Strong Q4 Revenue Beat
Revenue of $274 million in Q4 2025, +17% year-over-year and +9% sequentially; foreign currency added ~$6 million (≈2%) in the quarter.
Negative Updates
Gross Margin Pressure from Tariffs and Cost Absorption
GAAP gross margin was 36.1% and adjusted gross margin 37.6% in Q4; tariffs reduced gross margin by ~200 basis points year-over-year (50 bps worse than expected) and under-absorption of fixed costs (planned inventory management) further depressed margins versus revenue level.
Read all updates
Q4-2025 Updates
Negative
Strong Q4 Revenue Beat
Revenue of $274 million in Q4 2025, +17% year-over-year and +9% sequentially; foreign currency added ~$6 million (≈2%) in the quarter.
Read all positive updates
Company Guidance
The company guided for Q1 2026 revenue of $235 million to $265 million with adjusted gross margin of 37%–39% (including an estimated tariff headwind of ~150 basis points), operating expenses of $90 million–$92 million, adjusted EBITDA of $25 million–$40 million, and adjusted EPS of $0.10–$0.40 on ~42.5 million diluted shares; management noted book‑to‑bill was firmly above one (though some medical/systems bookings will ship after Q1), expects tariffs to persist at a moderated level, anticipates operating expenses to increase modestly through the year to accelerate growth initiatives, and reaffirmed 2026 CapEx of $90 million–$100 million (with underlying CapEx ≈5% of revenue) while highlighting margin upside as revenue growth improves fixed‑cost absorption toward the company’s >40% gross‑margin target.

IPG Photonics Financial Statement Overview

Summary
Mixed fundamentals: a very strong, debt-free balance sheet (88) provides resilience, but the income statement is only in early recovery (54) and 2025 cash flow weakened with slightly negative free cash flow (46), raising near-term execution and funding-quality concerns.
Income Statement
54
Neutral
Balance Sheet
88
Very Positive
Cash Flow
46
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.00B977.13M1.29B1.43B1.46B
Gross Profit381.46M338.15M541.70M555.41M696.40M
EBITDA111.95M75.92M301.19M321.97M449.09M
Net Income31.10M-181.53M218.88M109.91M278.42M
Balance Sheet
Total Assets2.42B2.29B2.70B2.74B3.17B
Cash, Cash Equivalents and Short-Term Investments839.33M930.19M1.18B1.18B1.51B
Total Debt0.0017.96M18.26M38.05M58.13M
Total Liabilities296.15M264.79M283.51M357.92M423.32M
Stockholders Equity2.13B2.02B2.42B2.39B2.75B
Cash Flow
Free Cash Flow-3.45M149.37M185.50M102.51M266.59M
Operating Cash Flow75.34M247.90M295.99M212.65M389.70M
Investing Cash Flow-265.23M208.73M-237.55M296.95M-416.28M
Financing Cash Flow-54.19M-339.62M-236.38M-514.55M-125.07M

IPG Photonics Technical Analysis

Technical Analysis Sentiment
Positive
Last Price113.94
Price Trends
50DMA
116.75
Negative
100DMA
97.66
Positive
200DMA
88.42
Positive
Market Momentum
MACD
-1.02
Positive
RSI
46.81
Neutral
STOCH
33.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPGP, the sentiment is Positive. The current price of 113.94 is below the 20-day moving average (MA) of 117.15, below the 50-day MA of 116.75, and above the 200-day MA of 88.42, indicating a neutral trend. The MACD of -1.02 indicates Positive momentum. The RSI at 46.81 is Neutral, neither overbought nor oversold. The STOCH value of 33.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IPGP.

IPG Photonics Risk Analysis

IPG Photonics disclosed 36 risk factors in its most recent earnings report. IPG Photonics reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

IPG Photonics Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$2.41B12.1511.84%-2.04%8.84%
74
Outperform
$14.06B38.1422.70%39.37%40.87%
70
Outperform
$4.23B22.9414.07%1.52%-0.58%-6.67%
63
Neutral
$49.35B26.7812.81%2.29%8.01%10.41%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$4.81B98.081.48%-7.49%
55
Neutral
$7.68B-177.61-7.22%20.60%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IPGP
IPG Photonics
113.94
61.90
118.95%
ASX
ASE Technology Holding Co
22.28
14.89
201.33%
NVMI
Nova
442.24
271.63
159.21%
PLAB
Photronics
40.85
23.48
135.18%
SMTC
Semtech
82.65
54.34
191.95%
OLED
Universal Display
89.72
-21.40
-19.26%

IPG Photonics Corporate Events

Business Operations and StrategyLegal Proceedings
IPG Photonics Faces European Patent Ruling on Lasers
Negative
Mar 16, 2026
On March 16, 2026, IPG Photonics said the Local Division of the Unified Patent Court in Düsseldorf ruled that certain uses and designs of its adjustable mode beam lasers infringe a Trumpf European patent, affecting products sold in Germany, F...
Business Operations and StrategyLegal Proceedings
IPG Photonics Faces European Patent Ruling, Plans Appeal
Negative
Feb 25, 2026
On February 25, 2026, IPG Photonics announced that the Local Division of the Unified Patent Court in Mannheim, Germany ruled certain designs of its adjustable mode beam lasers used in welding and cutting infringed Trumpf’s European Patent 2,...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 17, 2026